Blog - Page 1406 of 5718

MondayMay 03, 2021 1:07 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Makes Headway into Canadian Cannabis Vape Market with 25,000 Unit Production Run

Production underway for 25,000 vape cartridges using PULL full spectrum oil formulations, including Super Lemon Haze, Grand Daddy Purple and Girl Scout Cookies/GSK Company estimates retail sales revenue for this production run will be approximately $750,000 60% of respondents in StatCan’s Canadian 2020 Cannabis Survey that used vaporizer for cannabis in the last 12 months used oil/extracts “Cannabis 2.0,” the colloquial term for legalization of cannabis derivatives in Canada late in 2019, represented the outset of new trends in how people consume cannabis products with the accessibility of goods like drinks and vape products. While some companies have devoted considerable…

MondayMay 03, 2021 12:51 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Eyes Rapid Progress to Clinical Studies for Psychedelic Drug Candidates

Cybin (NEO: CYBN) (OTCQB: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, has completed key in-vitro and in-vivo research studies. The company recently announced completion of its 20th pre-clinical study and the progression of two psychedelic drug candidates: CYB003 and CYB004. According to Cybin, the studies were completed in record time, in part due to close collaboration with the company’s partners and contractors. “Excellent teamwork and fully supportive partners have greatly facilitated the advancement of these two new therapeutic candidates with enhanced and improved properties,” said Michael Palfreyman, Cybin’s chief R&D officer, in a…

MondayMay 03, 2021 12:32 pm

Healthtech Solutions Inc. (HLTT) Adopts New Portfolio Model with Varian Bio Acquisition

McKinsey & Company notes that portfolio model is growing in popularity amongst companies and investors HLTT recently acquired precision oncology company Varian Biopharma Report shows that more than $5.5 billion in capital has been raised in past six years by companies with biotech portfolio models An emerging trend in biotechnology involves abandoning a single shot on goal approach in favor of a broader strategy with different portfolio companies under one umbrella. The old incubator approach with a new flare, the trend involves a portfolio manager utilizing a variety of skillsets to assemble a group of subsidiaries, each committed to a…

MondayMay 03, 2021 11:23 am

SRAX Inc. (NASDAQ: SRAX) Hosts First-Ever Sequire Cannabis Conference Featuring 40 Company Presentations, Exclusive Keynote Interviews

SRAX held first-ever virtual Sequire Cannabis Conference on April 20, 2021 Event featured over 40 cannabis company presentations, keynote appearances by Steve DeAngelo, Dr. Sue Sisley, Emily Paxhia, Steven Hawkins, Dr. Jeffrey Chen Sequire provides data analytics tools that help public companies track investor activity, such as investor tracking, warrant management, shareholder surveys Sequire has grown to over 3 million users across 183 companies since 2019 SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, recently held its first-ever virtual Sequire Cannabis Conference on April 20, 2021 (https://ibn.fm/nr7Pd).…

MondayMay 03, 2021 11:19 am

QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Releases Corporate Update

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, has provided a corporate update regarding its cannabis, functional mushroom and psilocybin business operations. The update notes that, in spite of COVID-19, its Pemberton, British Columbia facility is fully operational and in daily production. The company is focused on scalable entry into the U.S. market through a partnership with an Oregon-based, multistate operator (“MSO”). The company intends to produce its own branded products as well as white label products. In Canada, the company is ramping…

MondayMay 03, 2021 11:12 am

QualityStocksNewsBreaks – BAND Royalty Announces Planned Launch of Unique Music/Art NFT Collectibles

BAND Royalty, operated by Singapore-based LIBERTY IS PTE LTD, today announced the planned launch of its first music/art collectibles, the BAND NFTs Series 1, on May 5, 2021. Commissioned by phenomenal artists, the NFTs celebrate the world’s incredible diversity, inclusivity and varieties of music with a unique twist. Unlike NBA Topshots or CryptoKitties, owning just one of the 3,000 limited-edition BAND NFTs allows access to the BAND Music NFT ecosystem and the opportunity to share in BAND’s performance royalty music catalog. Over 50 top artists are represented, such as Beyonce, Jay-Z, Justin Timberlake, Cher, will.i.am, Timbaland, Missy Elliot and Rihanna.…

MondayMay 03, 2021 11:00 am

Infobird Co., Ltd (NASDAQ: IFBD) Taking Next Step in AI-driven Customer Engagement Field with IPO

Beijing-based Infobird has built rich experience in the customer engagement industry that covers SaaS solutions such as cloud call center, intelligent telemarketing, AI Chatbots, and has now closed its IPO on the NASDAQ exchange. Infobird’s artificial intelligence (“AI”) solutions help clients to minimize costs and maximize potential revenues. The company’s self-developed cloud-native architecture and patented AI technologies work with a no-code development platform to help companies focus their efforts and financial outlays where they are most needed. B2B artificial intelligence (“AI”) solutions company Infobird (NASDAQ: IFBD) is building next-level operations in tandem with the Beijing, China-based company’s April 20 IPO…

MondayMay 03, 2021 10:57 am

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Growth of Sequire Platform to Over 5 Million Retail Investors

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through its software-as-a-service (“SaaS”) platform, Sequire, today announced that Sequire has grown to over 5 million retail investors. The platform expanded from 3 million investors just months ago and continues to grow exponentially as SRAX plans to offer even more value through the development of the Sequire Investor Community. “Retail investors are more important now than ever, as they have been driving the market and companies are starting to pay attention,” said Christopher Miglino, CEO and founder of SRAX. “Data on who investors are…

MondayMay 03, 2021 10:38 am

QualityStocksNewsBreaks – DGTL Holdings Inc. (TSXV: DGTL) (OTCQB: DGTHF) (FSE: A2QB0L) Announces Q3 and YTD Financial Results

DGTL Holdings (TSXV: DGTL) (OTCQB: DGTHF) (FSE: A2QB0L), an integrated digital media, marketing and advertising technologies accelerator company, today released its financial results for both the three- and nine-month periods, ending Feb. 28, 2021, representing Q3, and YTD results for FYE 2021. DGTL reported $1,250,782 in revenue for the three months ending Feb. 28, 2021. Hashoff reflected $744,984 for the same quarter in 2019, representing a 68% growth in revenue. In addition, DGTL reported a 71% growth in revenue to $3,666,603 for the nine months ending Feb. 28, 2021, versus $2,142,484 for the same period in 2019. "Hashoff has executed…

MondayMay 03, 2021 10:20 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) Announces Partnership with Leading Educational Platform to Provide Psychedelic Therapy Training

Tryp Therapeutics (CSE: TRYP), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, has entered a master service agreement with Fluence, an expertise-driven educational platform that provides professional training in psychedelic therapy and psychedelic integration for psychiatrists, psychotherapists, social workers, and other healthcare practitioners. The partnership will provide design and training for the psychotherapeutic component of Tryp's clinical trial activities and will strengthen Tryp's capability to plan and implement clinical trials. The agreement will also enhance the company’s ability to make the most of the information gathered. Fluence has specific expertise in psychedelic clinical trials…

Site Search

Company Search